concept Updated 2026-08-06 Tags: Medicine, Cardiac-Surgery, Medical-Device, Transplant

Artificial Heart Bridge Therapy

Artificial heart bridge therapy is the source’s frame for using mechanical circulatory support when a patient’s heart cannot sustain life and donor organs are scarce. In 86.打开一颗心:那美好的仗,我已经打过了, [[StephenWestaby|Stephen Westaby / 史蒂芬·维斯塔比]] moves into artificial hearts and assist pumps because transplant alone cannot meet the need.

The episode presents several versions of the bridge. Ebol receives left-ventricular assist support and gradually improves after stroke; Ralph’s artificial-heart case extends life but later ends in infection, shock, and organ failure; Julie survives with the [[AB180BloodPump|AB180 blood pump]] even without a normal pulse; a boy named Svante is briefly mentioned through Berlin Heart-style support while waiting for transplant.

The concept matters because “bridge” is not automatically cure. Mechanical support can buy time, rest myocardium, or keep circulation moving, but it also creates bleeding, stroke, infection, monitoring, device-management, and ICU-handoff risks. It therefore sits inside Medical Risk Management and Medical Device Clinical Validation, not outside them.

Key Claims

  • Donor scarcity makes mechanical support clinically important even when the technology is imperfect.
  • Mechanical circulatory support can be a bridge to transplant, a bridge to recovery, or a temporary rescue device, depending on the patient’s condition.
  • Survival time is not the only outcome; neurological injury, infection, bleeding, device failure, family burden, and recovery quality all matter.
  • Early success stories can help a device project gain attention, but deaths and complications remain part of the evidence boundary.

Connections

  • [[StephenWestaby|Stephen Westaby / 史蒂芬·维斯塔比]] and [[RobertJarvik|Robert Jarvik / 罗伯特·贾维克]] - surgeon and artificial-heart figure in the episode.
  • [[AB180BloodPump|AB180 blood pump]] - concrete device case.
  • High-Risk Surgical Innovation - broader source pattern around clinical use at the edge of permission and evidence.
  • Medical Risk Management and Medical Device Clinical Validation - risk and validation frames.